LOVE241220C20000
- 18.00
- 0.000.00%
The Lovesac Newsroom
Here's the Major Earnings Before the Open Tomorrow
Examining the Future: Lovesac's Earnings Outlook
Roth MKM Maintains The Lovesac(LOVE.US) With Buy Rating, Raises Target Price to $42
Earnings Week Ahead: ORCL, GME, ADBE, COST, AVGO, M and More
Earnings Preview: The Lovesac to Report Financial Results Pre-market on December 12
The Lovesac Company Announces Third Quarter Fiscal 2025 Conference Call Date
Small Cap Momentum Stocks as Its Three-year Rate of Change Is Turning Into Positive Around
Lovesac Is Maintained at Buy by Canaccord Genuity
CCORF Maintains The Lovesac(LOVE.US) With Buy Rating, Raises Target Price to $45
The Lovesac Company's (NASDAQ:LOVE) P/E Is Still On The Mark Following 35% Share Price Bounce
Canadian Cannabis Producer Cannara Reports 43% YoY Revenue Growth, Boosts Market Share And Profitability
Cannara Biotech Brief: Also Citing Operating Income Up By 42%, Adjusted EBITDA by 33%, Net Income by 184% and Free Cash Flow by 117%
Charge Your Phone For FREE At Lovesac This Holiday Shopping Season
The 14% Return This Week Takes Lovesac's (NASDAQ:LOVE) Shareholders Five-year Gains to 138%
Lovesac Introduces Sactionals Reclining Seat: The World's Most Innovative Power Recliner
Roth MKM Maintains The Lovesac(LOVE.US) With Buy Rating, Raises Target Price to $35
Express News | Lovesac Co : Roth Mkm Raises Target Price to $35 From $31
Express News | Lovesac Co Gains in Volume Spike, Last up 6.1%
Craig-Hallum Maintains The Lovesac(LOVE.US) With Buy Rating
The Lovesac Company to Host Investor Day